Vertex (VRTX) Form 144: 1,020-Share Restricted Vesting

Vertex Pharmaceuticals notice of proposed sale relates to Common stock tied to a restricted stock vesting event of 1,020 shares dated 02/17/2026.

Rhea-AI Filing Summary

Vertex Pharmaceuticals notice of proposed sale relates to Common stock tied to a restricted stock vesting event of 1,020 shares dated 02/17/2026. The filing also lists recent open-market dispositions by Carmen R. Bozic totaling multiple transactions between 03/27/2026 and 06/15/2026 with individual share counts and proceeds disclosed.

Insights

Corporate Governance Analyst

Routine Form 144 notice tied to vested compensation and recent sales.

The filing lists a 1,020-share restricted stock vesting on 02/17/2026 and multiple reported dispositions by Carmen R. Bozic between 03/27/2026 and 06/15/2026. The entries present share counts and gross proceeds for each sale.

These entries are procedural disclosures of intended or completed sales; cash‑flow treatment and any lockup or resale limitations are not stated in the excerpt. Subsequent filings may show additional transaction details if required.

Key Figures

Restricted shares vesting: 1,020 shares Sale on 03/27/2026: 2,329 shares Sale on 05/12/2026: 6,988 shares +1 more

4 metrics

Restricted shares vesting 1,020 shares vesting date 02/17/2026

Sale on 03/27/2026 2,329 shares gross proceeds $1,050,262.55

Sale on 05/12/2026 6,988 shares gross proceeds $3,144,600.00

Sale on 06/15/2026 4,062 shares gross proceeds $1,827,900.00

Key Terms

Restricted Stock Vesting, Form 144, Fidelity Brokerage Services LLC

3 terms

Restricted Stock Vesting financial

"Restricted Stock Vesting | Issuer | 02/17/2026"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Form 144 regulatory

"CONTENT METADATA: "form_type": "144""

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Fidelity Brokerage Services LLC financial

"Common | Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Vertex (VRTX) Form 144 disclose?

It discloses a proposed sale of 1,020 shares tied to a restricted stock vesting on 02/17/2026. The filing also lists multiple sales by Carmen R. Bozic between 03/27/2026 and 06/15/2026 with share counts and gross proceeds.

Who is the selling/filing party in the VRTX Form 144?

The filing shows transactions attributed to Carmen R. Bozic and lists Fidelity Brokerage Services LLC as an intermediary. The excerpt ties the 1,020 shares to issuer compensation vesting on 02/17/2026.

How many shares were sold recently by Carmen R. Bozic per the filing?

The filing lists multiple dispositions: 2,329 on 03/27/2026, 6,988 on 05/12/2026, 1,354 on 05/15/2026, 1,974 on 05/29/2026, 1,745 on 06/05/2026, and 4,062 on 06/15/2026.

What proceeds are shown for the recent Carmen R. Bozic sales?

The excerpt reports gross proceeds for each sale, including $1,050,262.55 (03/27/2026) and $1,827,900.00 (06/15/2026), among others. Each transaction line in the filing pairs share counts with a dollar amount.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/18/2026 - 11:33 AM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001790029
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	VERTEX PHARMACEUTICALS INC / MA
SEC File Number	000-19319
Address of Issuer	50 NORTHERN AVENUE BOSTON MASSACHUSETTS 02210
Phone	6173416393
Name of Person for Whose Account the Securities are To Be Sold	Bozic Carmen
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1020	471413.40	253805417	06/18/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/17/2026	Restricted Stock Vesting	Issuer			1020	02/17/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Carmen R. Bozic 50 Northern Avenue Boston MA 02210	Common	03/27/2026	2329	1050262.55
Carmen R. Bozic 50 Northern Avenue Boston MA 02210	Common	05/12/2026	6988	3144600.00
Carmen R. Bozic 50 Northern Avenue Boston MA 02210	Common	05/15/2026	1354	613971.30
Carmen R. Bozic 50 Northern Avenue Boston MA 02210	Common	05/29/2026	1974	888300.00
Carmen R. Bozic 50 Northern Avenue Boston MA 02210	Common	06/05/2026	1745	785250.00
Carmen R. Bozic 50 Northern Avenue Boston MA 02210	Common	06/15/2026	4062	1827900.00

144: Remarks and Signature

Remarks
Date of Notice	06/18/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/20/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Carmen Bozic
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)